Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab vs Methotrexate in Elderly Unfit HNSCC
NCT01884623Phase 3Completed
- Sponsor
- Gustave Roussy
- Start
- Nov 2013
- Primary completion
- Oct 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of cetuximab in head and neck squamous cell carcinoma (HNSCC), sponsored by Gustave Roussy. Started Nov 2013; status: completed.
02
Drugs
cetuximab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01884623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01884623.